Literature DB >> 16466959

Founder mutation causing infantile GM1-gangliosidosis in the Gypsy population.

Ivanka Sinigerska1, David Chandler, Vijesh Vaghjiani, Irfet Hassanova, Rebecca Gooding, Amelia Morrone, Ivo Kremensky, Luba Kalaydjieva.   

Abstract

The Gypsies are a trans-national founder population of Asian descent, whose genetic heritage is still incompletely characterized. Here, we describe the first founder mutation leading to a lysosomal storage disorder in this population: R59H in GLB1, which causes infantile GM1-gangliosidosis. The R59H carrier rate is approximately 2% in the general Gypsy population and approximately 10% in the Rudari sub-isolate. Haplotype analysis suggests that the Gypsy diaspora may have contributed to the spread of this mutation to South America.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466959     DOI: 10.1016/j.ymgme.2005.12.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Carrier rates of four single-gene disorders in Croatian Bayash Roma.

Authors:  Ana Barešić; Marijana Peričić Salihović
Journal:  Genet Test Mol Biomarkers       Date:  2013-11-04

2.  Newborn screening for lysosomal storage disorders in hungary.

Authors:  Judit Wittmann; Eszter Karg; Sàndor Turi; Elisa Legnini; Gyula Wittmann; Anne-Katrin Giese; Jan Lukas; Uta Gölnitz; Michael Klingenhäger; Olaf Bodamer; Adolf Mühl; Arndt Rolfs
Journal:  JIMD Rep       Date:  2012-03-21

3.  Clinical and molecular characteristics of 11 Chinese probands with GM1 gangliosidosis.

Authors:  Yuyu Feng; Yonglan Huang; Xiaoyuan Zhao; Huiying Sheng; Yi Feng; Wen Zhang; Li Liu
Journal:  Metab Brain Dis       Date:  2018-09-28       Impact factor: 3.584

Review 4.  The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis.

Authors:  Frederick M Lang; Paul Korner; Mark Harnett; Ajith Karunakara; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2019-12-30       Impact factor: 4.797

5.  Rare Diseases in Glycosphingolipid Metabolism.

Authors:  Hongwen Zhou; Zhoulu Wu; Yiwen Wang; Qinyi Wu; Moran Hu; Shuai Ma; Min Zhou; Yan Sun; Baowen Yu; Jingya Ye; Wanzi Jiang; Zhenzhen Fu; Yingyun Gong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy.

Authors:  Benita C Percival; Yvonne L Latour; Cynthia J Tifft; Martin Grootveld
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

7.  Beta-galactosidase deficiencies and novel GLB1 mutations in three Chinese patients with Morquio B disease or GM1 gangliosidosis.

Authors:  Hong-Lin Lei; Jun Ye; Wen-Juan Qiu; Hui-Wen Zhang; Lian-Shu Han; Yu Wang; Xue-Fan Gu
Journal:  World J Pediatr       Date:  2012-11-15       Impact factor: 2.764

Review 8.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

9.  Population analysis of the GLB1 gene in South Brazil.

Authors:  Cléia Baiotto; Fernanda Sperb; Ursula Matte; Cláudia Dornelles da Silva; Renata Sano; Janice Carneiro Coelho; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

10.  Morquio-like dysostosis multiplex presenting with neuronopathic features is a distinct GLB1-related phenotype.

Authors:  Sylvia Stockler-Ipsiroglu; Nahid Yazdanpanah; Mojgan Yazdanpanah; Marioara Moisa Popurs; Nataliya Yuskiv; Mara Lúcia Schmitz Ferreira Santos; Chong Ae Kim; Carolina Fischinger Moura de Souza; Charles Marques Lourenço; Carlos Eduardo Steiner; Andressa Federhen; Luciana Giugliani; Débora Maria Bastos Pereira; Luz Elena Durán-Carabali; Roberto Giugliani
Journal:  JIMD Rep       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.